Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding
- 1 June 1990
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 54 (6) , 1926-1933
- https://doi.org/10.1111/j.1471-4159.1990.tb04893.x
Abstract
The binding of [3H]3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphonic acid ([3H]CPP), a rigid analogue of 2‐amino‐7‐phosphonoheptanoic acid (AP7) and reported to be a selective N‐methyld‐aspartate (NMDA) antagonist, was studied in rat striatal membranes using a centrifugation procedure to separate bound and free radioligand. [3H]CPP bound with high affinity (Kd= 272 nM) in a saturable, reversible, and protein concentration‐dependent manner, Specific binding was suggested to involve a single class of noninteracting binding sites. The most potent [[3H]CPP binding inhibitors tested were CPP, l‐glutamate, 2‐amino‐5‐phosphonovalerate, and AP7, NMDA, l‐aspartate, and α‐aminoadipate were also shown to be efficient in inhibiting the binding, whereas quisqualate, d,l‐2‐amino‐4‐phosphonobutyrate, kainate, l‐glutamate diethylester, and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid were found to be essentially inactive. These data are therefore consistent with the view that [3H]CPP selectively binds to NMDA receptors in the rat striatum. Lesions of intrastriatal neurons using local injections of kainic acid revealed a marked decrease in [3H]CPP binding, suggesting an almost exclusively postsynaptic location of binding sites in the striatum. Conversely, bilateral lesion of corticostriatal glutamatergic fibers resulted in an increased number of [3H]CPP striatal binding sites, providing evidence for a putative supersensitivity response to this striatal deafferentation. Interestingly, lesion of the nigrostriatal dopaminergic neurons using intranigral 6‐hydroxydopamine injections resulted, 2–3 weeks later, in a similar increase in the number of [3H]CPP striatal binding sites. These data suggest the occurrence of functional receptor‐receptor interregulations at the postsynaptic level between dopaminergic and NMDA receptors in complement with the interactions occurring at the presynaptic level between glutamatergic and dopaminergic nerve terminals.Keywords
This publication has 31 references indexed in Scilit:
- Homocysteic Acid as a Putative Excitatory Amino Acid Neurotransmitter: I. Postsynaptic Characteristics at N‐Methyl‐D‐Aspartate‐Type Receptors on Striatal Cholinergic InterneuronsJournal of Neurochemistry, 1988
- Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- NMDA Receptor Losses in Putamen from Patients with Huntington's DiseaseScience, 1988
- α‐[3H]Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding to Rat Striatal Membranes: Effects of Selective Brain LesionsJournal of Neurochemistry, 1988
- The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of ?-aspartic acid into the nucleus accumbensNeuropharmacology, 1988
- NMDA- and kainate-evoked GABA release from striatal neurones differentiated in primary culture: Differential blocking by phencyclidineNeuroscience Letters, 1988
- Comparative analysis of the effects of in vivo electrical stimulation of the frontal cortex and gamma-butyrolactone administration on dopamine and dihydroxyphenyl acetic acid (DOPAC) striatal contents in the ratNeurochemistry International, 1987
- Neuronal Phosphoproteins: Physiological and Clinical ImplicationsScience, 1984
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975